Global Irritable Bowel Syndrome Treatment Market Analysis 2015-2019 and Forecast 2020-2025

  • Ample Market Research

    The global Irritable Bowel Syndrome Treatment market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Irritable Bowel Syndrome Treatment by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

    Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

    Lubiprostone

    Linaclotide

    Eluxadoline

    Rifaximin

    Ramosetron Hydrochloride

    Others

    Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

    Abbott Laboratories

    Synergy Pharmaceuticals, Inc.

    Sucampo Pharmaceuticals, Inc.

    Valeant Pharmaceuticals International, Inc.

    Ardelyx, Inc.

    Astellas Pharma Inc.

    Novartis AG

    GlaxoSmithKline plc.

    Ironwood Pharmaceuticals, Inc.

    Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

    Hospital

    Clinic

    Home Care

    Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

    North America (U.S., Canada, Mexico)

    Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

    Asia-Pacific (China, India, Japan, Southeast Asia etc.)

    South America (Brazil, Argentina etc.)

    Middle East & Africa (Saudi Arabia, South Africa etc.)

     

  • Table of Contents

    1 Industry Overview

    1.1 Irritable Bowel Syndrome Treatment Industry

    Figure Irritable Bowel Syndrome Treatment Industry Chain Structure

    1.1.1 Overview

    1.1.2 Development of Irritable Bowel Syndrome Treatment

    1.2 Market Segment

    1.2.1 Upstream

    Table Upstream Segment of Irritable Bowel Syndrome Treatment

    1.2.2 Downstream

    Table Application Segment of Irritable Bowel Syndrome Treatment

    Table Global Irritable Bowel Syndrome Treatment Market 2015-2025, by Application, in USD Million

    1.3 Cost Analysis

    2 Industry Environment (PEST Analysis)

    2.1 Policy

    2.2 Economics

    2.3 Sociology

    2.4 Technology

    3 Irritable Bowel Syndrome Treatment Market by Type

    3.1 By Type

    3.1.1 Lubiprostone

    Table Major Company List of Lubiprostone

    3.1.2 Linaclotide

    Table Major Company List of Linaclotide

    3.1.3 Eluxadoline

    Table Major Company List of Eluxadoline

    3.1.4 Rifaximin

    Table Major Company List of Rifaximin

    3.1.5 Ramosetron Hydrochloride

    Table Major Company List of Ramosetron Hydrochloride

    3.1.6 Others

    Table Major Company List of Others

    3.2 Market Size

    Table Global Irritable Bowel Syndrome Treatment Market 2015-2019, by Type, in USD Million

    Figure Global Irritable Bowel Syndrome Treatment Market Growth 2015-2019, by Type, in USD Million

    Table Global Irritable Bowel Syndrome Treatment Market 2015-2019, by Type, in Volume

    Figure Global Irritable Bowel Syndrome Treatment Market Growth 2015-2019, by Type, in Volume

    3.3 Market Forecast

    Table Global Irritable Bowel Syndrome Treatment Market Forecast 2020-2025, by Type, in USD Million

    Table Global Irritable Bowel Syndrome Treatment Market Forecast 2020-2025, by Type, in Volume

    4 Major Companies List

    4.1 Abbott Laboratories (Company Profile, Sales Data etc.)

    4.1.1 Abbott Laboratories Profile

    Table Abbott Laboratories Overview List

    4.1.2 Abbott Laboratories Products & Services

    4.1.3 Abbott Laboratories Business Operation Conditions

    Table Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.2 Synergy Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)

    4.2.1 Synergy Pharmaceuticals, Inc. Profile

    Table Synergy Pharmaceuticals, Inc. Overview List

    4.2.2 Synergy Pharmaceuticals, Inc. Products & Services

    4.2.3 Synergy Pharmaceuticals, Inc. Business Operation Conditions

    Table Business Operation of Synergy Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.3 Sucampo Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)

    4.3.1 Sucampo Pharmaceuticals, Inc. Profile

    Table Sucampo Pharmaceuticals, Inc. Overview List

    4.3.2 Sucampo Pharmaceuticals, Inc. Products & Services

    4.3.3 Sucampo Pharmaceuticals, Inc. Business Operation Conditions

    Table Business Operation of Sucampo Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.4 Valeant Pharmaceuticals International, Inc. (Company Profile, Sales Data etc.)

    4.4.1 Valeant Pharmaceuticals International, Inc. Profile

    Table Valeant Pharmaceuticals International, Inc. Overview List

    4.4.2 Valeant Pharmaceuticals International, Inc. Products & Services

    4.4.3 Valeant Pharmaceuticals International, Inc. Business Operation Conditions

    Table Business Operation of Valeant Pharmaceuticals International, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.5 Ardelyx, Inc. (Company Profile, Sales Data etc.)

    4.5.1 Ardelyx, Inc. Profile

    Table Ardelyx, Inc. Overview List

    4.5.2 Ardelyx, Inc. Products & Services

    4.5.3 Ardelyx, Inc. Business Operation Conditions

    Table Business Operation of Ardelyx, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.6 Astellas Pharma Inc. (Company Profile, Sales Data etc.)

    4.6.1 Astellas Pharma Inc. Profile

    Table Astellas Pharma Inc. Overview List

    4.6.2 Astellas Pharma Inc. Products & Services

    4.6.3 Astellas Pharma Inc. Business Operation Conditions

    Table Business Operation of Astellas Pharma Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.7 Novartis AG (Company Profile, Sales Data etc.)

    4.7.1 Novartis AG Profile

    Table Novartis AG Overview List

    4.7.2 Novartis AG Products & Services

    4.7.3 Novartis AG Business Operation Conditions

    Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.8 GlaxoSmithKline plc. (Company Profile, Sales Data etc.)

    4.8.1 GlaxoSmithKline plc. Profile

    Table GlaxoSmithKline plc. Overview List

    4.8.2 GlaxoSmithKline plc. Products & Services

    4.8.3 GlaxoSmithKline plc. Business Operation Conditions

    Table Business Operation of GlaxoSmithKline plc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    4.9 Ironwood Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)

    4.9.1 Ironwood Pharmaceuticals, Inc. Profile

    Table Ironwood Pharmaceuticals, Inc. Overview List

    4.9.2 Ironwood Pharmaceuticals, Inc. Products & Services

    4.9.3 Ironwood Pharmaceuticals, Inc. Business Operation Conditions

    Table Business Operation of Ironwood Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

    5 Market Competition

    5.1 Company Competition

    Table Global Irritable Bowel Syndrome Treatment Sales Revenue 2015-2019, by Company, in USD Million

    Table Global Irritable Bowel Syndrome Treatment Sales Revenue Share 2015-2019, by Company, in USD Million

    Figure Global Irritable Bowel Syndrome Treatment Sales Revenue Share in 2019, by Company, in USD Million

    Table Global Irritable Bowel Syndrome Treatment Sales Volume 2015-2019, by Company, in Volume

    Table Global Irritable Bowel Syndrome Treatment Sales Volume Share 2015-2019, by Company, in Volume

    Figure Global Irritable Bowel Syndrome Treatment Sales Volume Share in 2019, by Company, in Volume

    5.2 Regional Market by Company

    Figure North America Irritable Bowel Syndrome Treatment Market Concentration, in 2019

    Figure Europe Irritable Bowel Syndrome Treatment Market Market Concentration, in 2019

    Figure Asia-Pacific Irritable Bowel Syndrome Treatment MMarket Concentration, in 2019

    Figure South America Irritable Bowel Syndrome Treatment Market Concentration, in 2019

    Figure Middle East & Africa Irritable Bowel Syndrome Treatment Market Concentration, in 2019

    6 Demand by End Market

    6.1 Demand Situation

    6.1.1 Demand in Hospital

    Figure Irritable Bowel Syndrome Treatment Demand in Hospital, 2015-2019, in USD Million

    Figure Irritable Bowel Syndrome Treatment Demand in Hospital, 2015-2019, in Volume

    6.1.2 Demand in Clinic

    Figure Irritable Bowel Syndrome Treatment Demand in Clinic, 2015-2019, in USD Million

    Figure Irritable Bowel Syndrome Treatment Demand in Clinic, 2015-2019, in Volume

    6.1.3 Demand in Home Care

    Figure Irritable Bowel Syndrome Treatment Demand in Home Care, 2015-2019, in USD Million

    Figure Irritable Bowel Syndrome Treatment Demand in Home Care, 2015-2019, in Volume

    6.2 Regional Demand Comparison

    Table Regional Demand Comparison List

    Table Major Application in Different Regions

    6.3 Demand Forecast

    Table Irritable Bowel Syndrome Treatment Demand Forecast 2020-2025, by Application, in USD Million

    Figure Irritable Bowel Syndrome Treatment Market Growth 2020-2025, by Application, in USD Million

    Figure Irritable Bowel Syndrome Treatment Market Share in 2025, by Application, in USD Million

    Table Irritable Bowel Syndrome Treatment Demand Forecast 2020-2025, by Application, in Volume

    Table Irritable Bowel Syndrome Treatment Market Growth 2020-2025, by Application, in Volume

    Table Irritable Bowel Syndrome Treatment Market Share in 2025, by Application, in Volume

    7 Region Operation

    7.1 Regional Production

    Table Irritable Bowel Syndrome Treatment Production 2015-2019, by Region, in USD Million

    Table Irritable Bowel Syndrome Treatment Production 2015-2019, by Region, in Volume

    7.2 Regional Market

    Table Global Irritable Bowel Syndrome Treatment Market 2015-2019, by Region, in USD Million

    Table Global Irritable Bowel Syndrome Treatment Market Share 2015-2019, by Region, in USD Million

    Table Global Irritable Bowel Syndrome Treatment Market 2015-2019, by Region, in Volume

    Table Global Irritable Bowel Syndrome Treatment Market Share 2015-2019, by Region, in Volume

    7.3 by Region

    7.3.1 North America

    7.3.1.1 Overview

    Figure North America Irritable Bowel Syndrome Treatment Market Size and Growth 2015-2019, in USD Million

    Figure North America Irritable Bowel Syndrome Treatment Market Size and Growth 2015-2019, in Volume

    7.3.1.2 by Country (U.S., Canada, Mexico)

    Table North America Irritable Bowel Syndrome Treatment Market Size 2015-2019, by Country, in USD Million

    Table North America Irritable Bowel Syndrome Treatment Market Size 2015-2019, by Country, in Volume

    7.3.2 Europe

    7.3.2.1 Overview

    Figure Europe Irritable Bowel Syndrome Treatment Market Size and Growth 2015-2019, in USD Million

    Figure Europe Irritable Bowel Syndrome Treatment Market Size and Growth 2015-2019, in Volume

    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

    Table Europe Irritable Bowel Syndrome Treatment Market Size 2015-2019, by Country, in USD Million

    Table Europe Irritable Bowel Syndrome Treatment Market Size 2015-2019, by Country, in Volume

    7.3.3 Asia-Pacific

    7.3.3.1 Overview

    Figure Asia-Pacific Irritable Bowel Syndrome Treatment Market Size and Growth 2015-2019, in USD Million

    Figure Asia-Pacific Irritable Bowel Syndrome Treatment Market Size and Growth 2015-2019, in Volume

    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

    Table Asia-Pacific Irritable Bowel Syndrome Treatment Market Size 2015-2019, by Country, in USD Million

    Table Asia-Pacific Irritable Bowel Syndrome Treatment Market Size 2015-2019, by Country, in Volume

    7.3.4 South America

    7.3.4.1 Overview

    Figure South America Irritable Bowel Syndrome Treatment Market Size and Growth 2015-2019, in USD Million

    Figure South America Irritable Bowel Syndrome Treatment Market Size and Growth 2015-2019, in Volume

    7.3.4.2 by Country (Brazil, Argentina etc.)

    Table South America Irritable Bowel Syndrome Treatment Market Size 2015-2019, by Country, in USD Million

    Table South America Irritable Bowel Syndrome Treatment Market Size 2015-2019, by Country, in Volume

    7.3.5 Middle East & Africa

    7.3.5.1 Overview

    Figure Middle East & Africa Irritable Bowel Syndrome Treatment Market Size and Growth 2015-2019, in USD Million

    Figure Middle East & Africa Irritable Bowel Syndrome Treatment Market Size and Growth 2015-2019, in Volume

    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

    Table Middle East & Africa Irritable Bowel Syndrome Treatment Market Size 2015-2019, by Country, in USD Million

    Table Middle East & Africa Irritable Bowel Syndrome Treatment Market Size 2015-2019, by Country, in Volume

    7.4 Regional Import & Export

    7.5 Regional Forecast

    Table Irritable Bowel Syndrome Treatment Market Forecast 2020-2025, by Region, in USD Million

    Table Irritable Bowel Syndrome Treatment Market Forecast 2020-2025, by Region, in Volume

    8 Marketing & Price

    8.1 Price and Margin

    8.1.1 Price Trends

    8.1.2 Factors of Price Change

    Table Price Factors List

    8.1.3 Manufacturers Gross Margin Analysis

    8.2 Marketing Channel

    Figure Marketing Channels Overview

    9 Research Conclusion

     

This is a single user license, allowing one specific user access to the product.

This is an enterprise license, allowing all employees within your organisation access to the product.

Need Assistance ?

Our Clients